https://www.ycombinator.com/companies/indee-labs
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Chief Executive Officer
email: ryan@indeelabs.com
linkedin: linkedin.com/in/rpawell
Scientist
email: brandon@indeelabs.com
linkedin: linkedin.com/in/brandon-sytsma-50b630170
Scientist
email: None
linkedin: linkedin.com/in/rigbyj
Senior Scientist
email: None
linkedin: linkedin.com/in/struan-bourke-a4576410